Tuesday, November 17, 2026

WHO warns progress on antimicrobial resistance falls short of 2030 targets

Most countries now have national plans to tackle antimicrobial resistance, but few have put the funding in place to implement them, the World Health Organization warned on Monday. The UN health agency said the world was falling behind on efforts to contain drug-resistant infections, which threaten millions of lives and could undermine decades of medical advances.



Issued on: 17/11/2026 - RFI

Antibiotics such as Amoxicillin are misused in some countries, as many patients cannot afford a doctor's visit or the medication, say experts.
 © Getty Image - Tek image /Scienc ephoto library

The warning comes in an annual survey conducted by the World Health Organization (WHO), alongside the United Nations Environment Programme (UNEP), the World Organisation for Animal Health and the Food and Agriculture Organisation (FAO).

Of the 183 countries surveyed, 173 reported having a national action plan to tackle antimicrobial resistance (AMR), up from just 79 in 2017. However, only 42 said their plans were both funded and implemented.

The findings highlight a growing gap between government commitments and concrete action, as resistance to antibiotics and other medicines threatens the future of modern medicine.

Antimicrobial resistance occurs when bacteria and other microorganisms evolve and no longer respond to medicines designed to treat them – a process accelerated by the misuse and overuse of antibiotics and other drugs.

At the UN General Assembly in 2024, countries agreed on a series of targets for 2030 aimed at tackling the problem, which experts warn could undermine decades of medical advances.

"Procedures we now take for granted become far riskier when antibiotics and antimicrobials no longer work," said Jean Pierre Nyemazi, acting director of the WHO's AMR department.

Nyemazi warned that the development of new antibiotics was failing to keep pace with the spread of resistance.

According to the WHO, one in six laboratory-confirmed bacterial infections is resistant to antibiotics, while drug-resistant infections could contribute to more than 39 million deaths worldwide over the next 25 years if current trends persist.

Prevention falls short

The 2026 survey highlighted a critical gap in infection prevention – one of the most effective ways to reduce the need for antibiotics.

The WHO said 128 countries now have national infection prevention and control programmes and guidelines, up from 90 in 2018.

However, only 69 countries, or 38 percent, have implemented these programmes nationwide – well short of the 2030 target of 90 percent.

While 131 countries reported having a national reference laboratory capable of testing antibiotic resistance in common bacteria, only 66 were able to test for both bacterial and fungal resistance.

Countries agreed in 2024 to work towards ensuring that 80 percent have such capabilities by 2030.

To help close the gap, the WHO has released two toolkits designed to strengthen diagnostic capacity – one outlining essential tests and another detailing laboratory procedures.

Surveillance improves, but gaps remain

Surveillance systems have expanded significantly, with 113 countries now monitoring antibiotic use and 109 tracking resistance, compared with 65 and 39 countries respectively in 2017.

However, only 21 countries reported integrating both sets of data.

The WHO says combining information on antibiotic use and resistance is essential to understanding how the use of these medicines drives resistance – and to helping governments develop more effective strategies to contain its spread.

No comments: